Literature DB >> 18724620

Angiogenesis as a therapeutic target in cancer.

Gireesh Kumaran1, Andrew R Clamp, Gordon C Jayson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18724620      PMCID： PMC4952946          DOI： 10.7861/clinmedicine.8-4-455

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  8 in total

1.  Etv2 and fli1b function together as key regulators of vasculogenesis and angiogenesis.

Authors:  Michael P Craig; Viktorija Grajevskaja; Hsin-Kai Liao; Jorune Balciuniene; Stephen C Ekker; Joo-Seop Park; Jeffrey J Essner; Darius Balciunas; Saulius Sumanas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-26       Impact factor: 8.311

Review 2.  Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.

Authors:  Brahma N Singh; Sharmila Shankar; Rakesh K Srivastava
Journal:  Biochem Pharmacol       Date:  2011-07-30       Impact factor: 5.858

Review 3.  Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets.

Authors:  Armelle T Mbaveng; Victor Kuete; Thomas Efferth
Journal:  Front Pharmacol       Date:  2017-06-02       Impact factor: 5.810

4.  An evaluation of the anti-angiogenic effect of the Korean medicinal formula "Sa-mi-yeon-geon-tang" in vitro and in ovo.

Authors:  Jin-Mu Yi; Ok-Sun Bang; No Soo Kim
Journal:  BMC Complement Altern Med       Date:  2015-03-05       Impact factor: 3.659

5.  Ethanol extract of Gleditsia sinensis thorn suppresses angiogenesis in vitro and in vivo.

Authors:  Jin-Mu Yi; Jong-Shik Park; Se-Mi Oh; Jun Lee; Jinhee Kim; Dal-Seok Oh; Ok-Sun Bang; No Soo Kim
Journal:  BMC Complement Altern Med       Date:  2012-12-04       Impact factor: 3.659

6.  Stilbene glycosides are natural product inhibitors of FGF-2-induced angiogenesis.

Authors:  Sajjad Hussain; Mark Slevin; Nessar Ahmed; David West; Muhammad Iqbal Choudhary; Humera Naz; John Gaffney
Journal:  BMC Cell Biol       Date:  2009-04-23       Impact factor: 4.241

7.  Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway.

Authors:  Zhiyu Wang; Neng Wang; Shouwei Han; Dongmei Wang; Suilin Mo; Linzhong Yu; Hui Huang; Kamchuen Tsui; Jiangang Shen; Jianping Chen
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

8.  Anti-angiogenic potential of an ethanol extract of Annona atemoya seeds in vitro and in vivo.

Authors:  Jin-Mu Yi; Jong-Shik Park; Jun Lee; Jin Tae Hong; Ok-Sun Bang; No Soo Kim
Journal:  BMC Complement Altern Med       Date:  2014-09-23       Impact factor: 3.659
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.